Several novel fluorinated fluoresceins (Oregon Green dyes) were
prepared by the reaction of
fluororesorcinols with phthalic anhydride and its derivatives. A
novel regiospecific synthesis of
fluororesorcinols was key to the successful synthesis of these new
fluorophores. (Polyfluoro)nitrobenzenes were reacted with 2 equiv of sodium methoxide followed by
reduction, hydrodediazoniation, and demethylation, giving the first straightforward synthesis
of 2-fluororesorcinol,
4-fluororesorcinol, 2,4-difluororesorcinol, and
2,4,5-trifluororesorcinol. These fluorinated
fluoresceins
have higher photostability and ionize at a lower pH
(pK
a = 3.3−6.1) than fluorescein
(pK
a = 6.5).
Some of the fluorinated fluoresceins have very high quantum yields
(0.85−0.97), which, in
combination with their lower pK
as and high
photostability, makes them superior fluorescent dyes
for use as reporter molecules in biological systems.
A cyclic peptide specific for type I collagen is derivatized with three {Gd(dtpa)} moieties to create a molecular MRI contrast agent for fibrosis imaging. In a mouse model of myocardial infarction (heart attack), collagen levels are elevated in the infarct zone. MRI after injection of the contrast agent selectively enhances and delineates the infarct zone (see preinjection and postinjection images); dtpa=diethylenetriaminepentaacetate.
Rationale and objectives-The observed relaxivity of gadolinium based contrast agents has contributions from the water molecule(s) that bind directly to the gadolinium ion (inner-sphere water), long lived water molecules and exchangeable protons that make up the second-sphere of coordination, and water molecules that diffuse near the contrast agent (outer-sphere). Inner-and second-sphere relaxivity can both be increased by optimization of the lifetimes of the water molecules and protons in these coordination spheres, the rotational motion of the complex, and the electronic relaxation of the gadolinium ion. We sought to identify new high relaxivity contrast agents by systematically varying the donor atoms that bind directly to gadolinium to increase inner-sphere relaxivity and concurrently including substituents that influence the second-sphere relaxivity.Methods-Twenty GdDOTA derivatives were prepared and their relaxivity determined in presence and absence of human serum albumin as a function of temperature and magnetic field. Data was analyzed to extract the underlying molecular parameters influencing relaxivity. Each compound had a common albumin-binding group and an inner-sphere donor set comprising the 4 tertiary amine N atoms from cyclen, an α-substituted acetate oxygen atom, two amide oxygen atoms, an inner-sphere water oxygen atom, and a variable donor group. Each amide nitrogen was substituted with different groups to promote hydrogen bonding with second-sphere water molecules.Results-Relaxivites at 0.47T and 1.4T, 37 °C, in serum albumin ranged from 16.0 to 58.1 mM −1 s −1 and from 12.3 to 34.8 mM −1 s −1 respectively. The reduction of inner-sphere water exchange typical of amide donor groups could be offset by incorporating a phosphonate or phenolate oxygen atom donor in the first coordination sphere resulting in higher relaxivity. Amide nitrogen substitution with pendant phosphonate or carboxylate groups increased relaxivity by as much as 88% compared to the N-methyl amide analog. Second-sphere relaxivity contributed as much as 24 mM −1 s −1 and 14 mM −1 s −1 at 0.47 and 1.4T respectively.Conclusions-Water/proton exchange dynamics in the inner-and second-coordination sphere can be predictably tuned by choice of donor atoms and second-sphere substituents resulting in high relaxivity agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.